Aflibercept and navigated versus conventional laser in diabetic macular oedema: a 12‐month randomized clinical trial.
Authors: Blindbæk, S. L., Peto, T., & Grauslund, J.
Presented: January 1, 2020
Type: Publications
No difference in need for retreatment was detected between treatment arms of aflibercept and navigated versus conventional laser. Our results suggest that with proper timing of focal/grid laser photocoagulation combination therapy may reduce the need for intravitreal therapy during the first year of treatment.
Related publications and webinars
- The treatment strategy and selected parameters presented in content listed here are solely the responsibility of the treating ophthalmologist, who is required to be familiar with the most recent literature/guidelines or recommendations, as well as with the usage of the Navilas Laser System according to the current Operator’s Manual.